Meropenem in Tanzania: NEMLIT level, who can prescribe it and STG references

Meropenem is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.

Last updated

Prescribe on DukadawaRxAsk DukadawaRx AI

New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.

Is meropenem available on the DukaDawa pharmacy network?

Not yet. Meropenem is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.

Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.

Is meropenem on the NEMLIT, and who can prescribe it?

Yes. Meropenem is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.

Level
S (zonal, special and national hospitals)
Category
Reserve Group Antibiotics (Anti-Infective Medicines)
Listed forms
Injection 500 mg, 1000 mg
Page
NEMLIT, p. 9
Who may prescribe at each NEMLIT level (STG/NEMLIT 7th edition, Part I, Table 1). Levels listed for this medicine are highlighted.
LevelFacilityWho may prescribe
ADispensarySpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer
BHealth centreSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer
CCouncil or district hospitalSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer
DRegional referral hospitalSpecialist, Medical Officer, Dental Officer
S (listed)Zonal, special and national hospitalsSpecialist

A medicine is listed from the lowest facility level where it should be available.

Where is meropenem in the Standard Treatment Guidelines?

The Standard Treatment Guidelines (7th edition, 2026) mention meropenem in 8 or more sections, most often section 9.3 Aspiration Syndromes (p. 208). See the STG for treatment details.

  • 9.3 Aspiration Syndromes, p. 208
  • 22.12.5 Oncological Emergencies > Febrile Neutropenia, p. 629
  • 1.15 Sepsis and Septic Shock, p. 46
  • 3.5.1 Hematopoietic Stem Cell Transplantation > Febrile Neutropenia, p. 88
  • 8.1.1.1 Infections of the Nervous System > Bacterial infections > Bacterial Meningitis, p. 169
  • 8.1.1.4 Infections of the Nervous System > Bacterial infections > Brain Abscess, p. 171
  • 8.5.2 Congenital Pediatric Nervous System Diseases > Management of Pediatric CSF Shunt Infections, p. 184
  • 9.1.1.2 Respiratory Tract Infections > Pneumonia > Pneumonia in Adults (Community Acquired Pneumonia), p. 202

Sections that mention Meropenem, most mentions first. Positions only: see the STG for treatment details.

Related medicines

All reserve group antibiotics on the NEMLIT

Sources

  • Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania

Page last updated

STG positions are section numbers and printed page numbers only.

This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.

For licensed prescribers and pharmacists. Not medical advice. Check the Standard Treatment Guidelines before prescribing.